Part I: Synthesis, cancer chemopreventive activity and molecular docking study of novel quinoxaline derivatives

被引:68
作者
Galal, Shadia A. [1 ]
Abdelsamie, Ahmed S. [1 ]
Tokuda, Harukuni [2 ]
Suzuki, Nobutaka [2 ]
Lida, Akira [3 ]
ElHefnawi, Mahmoud M. [4 ]
Ramadan, Raghda A. [4 ]
Atta, Mona H. E. [4 ]
El Diwani, Hoda I. [1 ]
机构
[1] Natl Res Ctr, Div Pharmaceut & Drug Ind, Dept Chem Nat & Microbial Prod, Cairo 12622, Egypt
[2] Kanazawa Univ, Grad Sch Med Sci, Clin R&D, Dept Complementary & Alternat Med, Kanazawa, Ishikawa 9208640, Japan
[3] Kinki Univ, Fac Agr, Nara 6318505, Japan
[4] Natl Res Ctr, Ctr Excellence Adv Sci, Biomed Informat & Chemoinformat Grp, Cairo 12622, Egypt
关键词
Synthesis; Quinoxalines; Anti-tumor promoter; Epstein-Barr virus; Two-stage carcinogenesis; 12-O-Tetradecanoylphorbol-13-acetate (TPA); Docking; Protein tyrosine kinase receptor (PTK); BIOLOGICAL EVALUATION; ANTITUMOR AGENT; ETHYL CARBOETHOXYFORMIMIDATE; ACID XK469; INHIBITORS; CELLS; ACTIVATION; COMPLEXES; RECEPTOR; ANALOGS;
D O I
10.1016/j.ejmech.2010.11.022
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The reaction of o-phenylene diamine and ethyl oxamate is reinvestigated and led to 3-aminoquinoxalin-2-(1H)-one rather than benzimidazole-2-carboxamide as was previously reported. The structure of the obtained quinoxaline has been confirmed by X-ray. The anti-tumor activity of synthesized quinoxalines 1-21 has been evaluated by studying their possible inhibitory effects on Epstein-Barr virus early antigen (EBV-EA) activation induced by 12-O-tetradecanoylphorbol-13-acetate (TPA). Among the studied compounds 1-21, compounds 12, 8, 13, 18, 17 and 19, respectively, demonstrated strong inhibitory effects on the EBV-EA activation without showing any cytotoxicity and their effects being stronger than that of a representative control, oleanolic acid. Furthermore, compound 12 exhibited a remarkable inhibitory effect on skin tumor promotion in an in vivo two-stage mouse skin carcinogenesis test using 7,12-dimethylbenz[a]anthracene (DMBA) as an initiator and TPA as a promoter. The result of the present investigation indicated that compound 12 might be valuable as a potent cancer chemopreventive agent. Moreover, the molecular docking into PTK (PDB: 1t46) has been done for lead optimization of the aforementioned compounds as potential PTK inhibitors. (C) 2010 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:327 / 340
页数:14
相关论文
共 40 条
[1]   Novel benzimidazole-pyrimidine conjugates as potent antitumor agents [J].
Abdel-Mohsen, Heba T. ;
Ragab, Fatma A. F. ;
Ramla, Mostafa M. ;
El Diwani, Hoda I. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (06) :2336-2344
[2]  
Abele E., 2007, CHEM HETEROCYCL COMP, V43, P220, DOI [10.1007/s10593-019-02532-310.1007/s10593-007-0034-9, DOI 10.1007/S10593-007-0034-9]
[3]   Microwave assisted synthesis and antimicrobial activity of 2-quinoxalinone-3-hydrazone derivatives [J].
Ajani, Olayinka O. ;
Obafemi, Craig A. ;
Nwinyi, Obinna C. ;
Akinpelu, David A. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (01) :214-221
[4]   SIR92 - a program for automatic solution of crystal structures by direct methods [J].
ALTOMARE, A ;
CASCARANO, G ;
GIACOVAZZO, G ;
GUAGLIARDI, A ;
BURLA, MC ;
POLIDORI, G ;
CAMALLI, M .
JOURNAL OF APPLIED CRYSTALLOGRAPHY, 1994, 27 :435-435
[5]   Synthesis, antiprotozoal and anticancer activity of substituted 2-trifluoromethyl- and 2-pentafluoroethylbenzimidazoles [J].
Andrzejewska, M ;
Yépez-Mulia, L ;
Cedillo-Rivera, R ;
Tapia, A ;
Vilpo, L ;
Vilpo, J ;
Kazimierczuk, Z .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2002, 37 (12) :973-978
[6]   Regioselectivity in preparation of unsymmetrically substituted 3-aminoquinoxalin-2(1H)-ones [J].
Csikós, E ;
Gönczi, C ;
Podányi, B ;
Tóth, G ;
Hermecz, I .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1999, (13) :1789-1793
[7]  
Eckhardt Sandor, 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P419, DOI 10.2174/1568011024606389
[8]   New transition metal ion complexes with benzimidazole-5-carboxylic acid hydrazides with antitumor activity [J].
Galal, Shadia A. ;
Hegab, Khaled H. ;
Kassab, Ahmed S. ;
Rodriguez, Mireya L. ;
Kerwin, Sean M. ;
El-Khamry, Abdel-Mo'men A. ;
El Diwani, Hoda I. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2009, 44 (04) :1500-1508
[9]   Synthesis, characterization and in vitro cytotoxic, mutagenic and antimicrobial activity of platinum(II) complexes with substituted benzimidazole ligands [J].
Gümüs, F ;
Pamuk, I ;
Özden, T ;
Yildiz, S ;
Diril, N ;
Öksüzoglu, E ;
Gür, S ;
Özkul, A .
JOURNAL OF INORGANIC BIOCHEMISTRY, 2003, 94 (03) :255-262
[10]   Design, synthesis, and biological evaluation of analogues of the antitumor agent, 2-{4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy}propionic acid (XK469) [J].
Hazeldine, ST ;
Polin, L ;
Kushner, J ;
Paluch, J ;
White, K ;
Edelstein, M ;
Palomino, E ;
Corbett, TH ;
Horwitz, JP .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (11) :1758-1776